RankAlpha logo
Back to Rankings

EVH

Evolent HealthA
NYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
View Chart
Current thesis
The constructive read is that management reiterated full-year guidance, narrowed the GAAP loss year over year, and pointed to Q3 implementations plus a payer expansion that could materially lift revenue if approvals and launches stay on time [#8-K-2026-05-07].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -5.4.
What can break
Adjusted EBITDA margin fell to 4.4% from 7.6% year over year, so revenue growth is not yet converting into stronger near-term profitability.
Momentum
88
Value
49
Sentiment
52
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.70 · Bull $5.40 · Bear $3.30
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $5.18
Why
Momentum88 · Δ7d -5.4
Value49 · Δ7d -0.1
Sentiment52 · Δ7d -2.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
88
34% active weight
Current posture
7d trendSoftening
Δ7d
-5.4
Δ21d
-4.3
Value
49
32% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+0.3
Sentiment
52
33% active weight
Current posture
7d trendSoftening
Δ7d
-2.5
Δ21d
+2.6
Why this grade

Composite grade A. Momentum 88.0 / Value 49.0 / Sentiment 51.6

Fundamentals (TTM)
As of 2026-06-01
Market Cap
$469.05M
Beta
0.27
Shares Out
111.6M
P/E (TTM) · Derived
-0.8
P/S (TTM)
0.21
P/FCF (TTM) · Derived
-7.04
Rev YoY
-22.8%
EPS YoY
+13.2%
Gross Margin
+18.4%
Op Margin
-1.7%
Net Debt
$557.78M
Current Ratio
1.33
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology